VIKASLIFE.NS
Vikas Lifecare Limited [VIKASLIFE.NS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
VIKASLIFE.NS Stock Summary
Top 10 Correlated ETFs
VIKASLIFE.NS
Top 10 Correlated Stocks
VIKASLIFE.NS
In the News
VIKASLIFE.NS Financial details
Company Rating
-
Market Cap
7.18B
Income
-16.25M
Revenue
4.67B
Book val./share
2.89
Cash/share
0.1
Dividend
-
Dividend %
-
Employees
59
Optionable
No
Shortable
Yes
Earnings
23 Jan 2024
P/E
-375.47
Forward P/E
-
PEG
34.23
P/S
1.54
P/B
1.73
P/C
50
P/FCF
-
Quick Ratio
2.16
Current Ratio
2.51
Debt / Equity
0.07
LT Debt / Equity
0.04
-
-
EPS (TTM)
-0.03
EPS next Y
-
EPS next Q
-
EPS this Y
-138.71%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
17.42%
Revenue Q/Q
17.33%
EPS Q/Q
-25%
-
-
-
-
SMA20
4.61%
SMA50
-10.41%
SMA100
60.45%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-0.01%
Gross Margin
6%
Oper. Margin
-1%
Profit Margin
-
Payout
-
Shs Outstand
1.44B
Shs Float
1.27B
-
-
-
-
Target Price
-
52W Range
2.7-7.05
52W High
-28.57%
52W Low
+150%
RSI
50.09
Rel Volume
0.56
Avg Volume
26.9M
Volume
14.98M
Perf Week
-0.99%
Perf Month
12.36%
Perf Quarter
53.85%
Perf Half Y
75.44%
-
-
-
-
Beta
1.436
-
-
Volatility
0.05%, 0.2%
Prev Close
-0.99%
Price
5
Change
1.01%
VIKASLIFE.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
| Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 2.68 | 1.7 | 0.94 | 3.22 | 3.65 | |
| Net income per share | 0.02 | 0.02 | -0.04 | 0.31 | -0.12 | |
| Operating cash flow per share | -0.15 | 0.04 | -0.1 | -0.16 | -0.84 | |
| Free cash flow per share | -0.16 | 0.04 | -0.12 | -0.3 | -0.98 | |
| Cash per share | 0.08 | 0 | 0 | 0.11 | 0.09 | |
| Book value per share | 1.13 | 0.58 | 0.84 | 2.13 | 2.54 | |
| Tangible book value per share | 1.13 | 0.58 | 0.84 | 1.96 | 2.41 | |
| Share holders equity per share | 1.13 | 0.58 | 0.84 | 2.13 | 2.54 | |
| Interest debt per share | 0.56 | 0.5 | 0.57 | 0.26 | 0.25 | |
| Market cap | 4.1B | 1.1B | 2.04B | 4.95B | 4.38B | |
| Enterprise value | 4.47B | 1.5B | 2.45B | 5.11B | 4.58B | |
| P/E ratio | 212.67 | 78.59 | -58.14 | 17.26 | -28.6 | |
| Price to sales ratio | 1.92 | 0.71 | 2.71 | 1.65 | 0.92 | |
| POCF ratio | -35.29 | 29.12 | -26.5 | -33.27 | -3.97 | |
| PFCF ratio | -32.75 | 33.59 | -22.24 | -17.62 | -3.43 | |
| P/B Ratio | 4.55 | 2.05 | 3.05 | 2.48 | 1.32 | |
| PTB ratio | 4.55 | 2.05 | 3.05 | 2.48 | 1.32 | |
| EV to sales | 2.1 | 0.97 | 3.27 | 1.7 | 0.96 | |
| Enterprise value over EBITDA | 45.42 | 12.26 | 33.5 | 988.79 | -28.54 | |
| EV to operating cash flow | -38.53 | 39.82 | -31.91 | -34.31 | -4.16 | |
| EV to free cash flow | -35.76 | 45.93 | -26.79 | -18.17 | -3.59 | |
| Earnings yield | 0 | 0.01 | -0.02 | 0.06 | -0.03 | |
| Free cash flow yield | -0.03 | 0.03 | -0.04 | -0.06 | -0.29 | |
| Debt to equity | 0.44 | 0.76 | 0.63 | 0.12 | 0.09 | |
| Debt to assets | 0.16 | 0.16 | 0.28 | 0.07 | 0.07 | |
| Net debt to EBITDA | 3.83 | 3.29 | 5.68 | 29.77 | -1.3 | |
| Current ratio | 1.28 | 0.88 | 1.41 | 1.26 | 2.14 | |
| Interest coverage | 1.11 | 1.75 | 1.82 | -1.78 | -8.28 | |
| Income quality | -4.14 | 1.5 | 5.12 | -0.38 | 5.15 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0.01 | 0.02 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.04 | 0 | 0 | 0.05 | 0.04 | |
| Capex to operating cash flow | 0.08 | -0.13 | 0.19 | 0.89 | 0.16 | |
| Capex to revenue | 0 | 0 | -0.02 | -0.04 | -0.04 | |
| Capex to depreciation | -1.25 | -0.68 | -2.15 | -9.57 | -5.8 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0.79 | 0.45 | 0.91 | 3.84 | 2.59 | |
| ROIC | 0.03 | 0.05 | 0.15 | -0.01 | -0.04 | |
| Return on tangible assets | 0.01 | 0.01 | -0.02 | 0.09 | -0.04 | |
| Graham Net | -0.27 | -0.91 | -0.86 | -0.27 | 0.26 | |
| Working capital | 404.81M | -235.92M | 273.43M | 273.38M | 1.21B | |
| Tangible asset value | 794.32M | 535.23M | 666.7M | 1.83B | 3.14B | |
| Net current asset value | 321.17M | -342.51M | 109.94M | 110.5M | 1.06B | |
| Invested capital | 0.44 | 0.76 | 0.63 | 0.12 | 0.09 | |
| Average receivables | 892.13M | 1.43B | 681.86M | 480.27M | 1.39B | |
| Average payables | 496.31M | 1.06B | 799.73M | 521.49M | 627.22M | |
| Average inventory | 170.2M | 292.82M | 287.51M | 278.31M | 205.1M | |
| Days sales outstanding | 257.78 | 320.82 | 0 | 116.51 | 139.84 | |
| Days payables outstanding | 163.94 | 315.19 | 215.57 | 83.66 | 47.51 | |
| Days of inventory on hand | 51.25 | 78.17 | 155.55 | 35.76 | 10.12 | |
| Receivables turnover | 1.42 | 1.14 | 0 | 3.13 | 2.61 | |
| Payables turnover | 2.23 | 1.16 | 1.69 | 4.36 | 7.68 | |
| Inventory turnover | 7.12 | 4.67 | 2.35 | 10.21 | 36.05 | |
| ROE | 0.02 | 0.03 | -0.05 | 0.14 | -0.05 | |
| Capex per share | -0.01 | -0.01 | -0.02 | -0.14 | -0.13 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q2
| Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 1.01 | 1.14 | 0.97 | 0.66 | 0.95 | |
| Net income per share | 0.02 | 0.05 | -0.22 | 0.08 | 0.06 | |
| Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Cash per share | 0.07 | 0 | 0.09 | 0 | 0.1 | |
| Book value per share | 2.35 | 0 | 2.72 | 0 | 2.89 | |
| Tangible book value per share | 2.23 | 0 | 2.58 | 0 | 2.65 | |
| Share holders equity per share | 2.35 | 0 | 2.72 | 0 | 2.89 | |
| Interest debt per share | 0.1 | 0 | 0.26 | 0 | 0.21 | |
| Market cap | 5.94B | 5.24B | 4.09B | 4.67B | 6.53B | |
| Enterprise value | 6.02B | 0 | 4.29B | 0 | 6.73B | |
| P/E ratio | 63.19 | 22.25 | -3.8 | 9.69 | 22.29 | |
| Price to sales ratio | 4.51 | 3.91 | 3.46 | 4.72 | 5.63 | |
| POCF ratio | 0 | 0 | 0 | 0 | 0 | |
| PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
| P/B Ratio | 1.94 | 0 | 1.23 | 0 | 1.85 | |
| PTB ratio | 1.94 | 0 | 1.23 | 0 | 1.85 | |
| EV to sales | 4.56 | 0 | 3.64 | 0 | 5.8 | |
| Enterprise value over EBITDA | 104.19 | 0 | -14.08 | 0 | 73.15 | |
| EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
| Earnings yield | 0 | 0.01 | -0.07 | 0.03 | 0.01 | |
| Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
| Debt to equity | 0.04 | 0 | 0.09 | 0 | 0.07 | |
| Debt to assets | 0.03 | 0 | 0.07 | 0 | 0.06 | |
| Net debt to EBITDA | 1.24 | 0 | -0.68 | 0 | 2.21 | |
| Current ratio | 1.99 | 0 | 2.14 | 0 | 2.51 | |
| Interest coverage | 18.71 | 7.74 | -25.78 | 26.96 | 12.62 | |
| Income quality | 0 | 0 | 0 | 0 | 0 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.04 | 0 | 0.04 | 0 | 0.07 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0.97 | 0 | 3.67 | 0 | 1.97 | |
| ROIC | 0.01 | 0 | -0.07 | 0 | 0.02 | |
| Return on tangible assets | 0.01 | 0 | -0.06 | 0 | 0.02 | |
| Graham Net | 0.01 | 0 | 0.27 | 0 | 0.29 | |
| Working capital | 865.6M | 0 | 1.21B | 0 | 1.23B | |
| Tangible asset value | 2.92B | 0 | 3.14B | 0 | 3.23B | |
| Net current asset value | 686.51M | 0 | 1.06B | 0 | 1.02B | |
| Invested capital | 0.04 | 0 | 0.09 | 0 | 0.07 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 0 | 0 | 0 | 0 | 0 | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 77.42 | 0 | 138.99 | 0 | 126.96 | |
| Days payables outstanding | 32.85 | 0 | 46.78 | 0 | 28.54 | |
| Days of inventory on hand | 18.98 | 0 | 9.97 | 0 | 4.28 | |
| Receivables turnover | 1.16 | 0 | 0.65 | 0 | 0.71 | |
| Payables turnover | 2.74 | 0 | 1.92 | 0 | 3.15 | |
| Inventory turnover | 4.74 | 0 | 9.03 | 0 | 21.02 | |
| ROE | 0.01 | 0 | -0.08 | 0 | 0.02 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
VIKASLIFE.NS Frequently Asked Questions
What is Vikas Lifecare Limited stock symbol ?
Vikas Lifecare Limited is a IN stock and trading under the symbol VIKASLIFE.NS
What is Vikas Lifecare Limited stock quote today ?
Vikas Lifecare Limited stock price is $5 today.
Is Vikas Lifecare Limited stock public?
Yes, Vikas Lifecare Limited is a publicly traded company.
Company Profile
- Volume Average 26.9M
- Market Capitalization 7.18B
- Employee 59
- CEO Mr. Vijay Kumar Sharma
- Headquarters New Delhi,IN
- IPO Date 2019-05-08
-
Website
https://www.vikaslifecarelimited.com 
Vikas Lifecare Limited engages in the trading of various chemicals compounds, polymers, PVC resins, plastic granules, and products related to plastic industry in India. It operates through Real Estate, Trading- Polymers, Trading-Cashew Nuts, and Manufacturing divisions. The company is also involved in the real estate business; and the manufacture of recycled material for automotive, packaging, sheathing, and textile industries. In addition, it manufactures and sells polymer compounds, which include PE, PVC, V blend SOE, and polypropylene compounds, as well as thermo plastic rubber; deals in FMCG, cashew nuts, aluminum foils, and processed food products. Vikas Lifecare Limited also exports its products. The company was formerly known as Vikas Multicorp Limited and changed its name to Vikas Lifecare Limited in April 2021. Vikas Lifecare Limited was incorporated in 1995 and is based in New Delhi, India.
